Telangana Industries Minister K T Rama Rao on Monday said Hyderabad's position as the 'vaccine capital of the world' was further bolstered following the COVID-19 pandemic.
He said it is a matter of pride that the world is looking towards the country and Hyderabad, the capital city of Telangana state.
The visit of foreign envoys from different countries and that of Prime Minister Narendra Modi to 'Genome Valley' in the city is testimony to the cluster's significance in the global context, he said.
Genome Valley is an organised cluster for life-sciences R&D with a number of companies located there.
"Our dream and vision of growing the life-sciences industry in Telangana to over USD 100 billion looks plausible and we remain committed to it," he said while speaking at the inauguration of BioAsia, an annual biotechnology and life- sciences forum, organised by the government of Telangana.
Life-sciences sector in the state has attracted new investments to the tune of about Rs 3,700 crore in the last one year with an employment potential for around 14,000 people, Rama Rao said.
Meanwhile, Bharat Biotech CMD Krishna Ella said the city would contribute significantly to vaccine production and related areas in the future.
A substantial chunk of vaccine production involving different reputed companies comes from the city, he said.
However, it does not get much publicity, he said.
"The pandemic vaccines, anything in the future. It will come only from Hyderabad. That's also please (be) assured (of) that. Whether it comes from BE or Bharat Biotech. It doesn't matter. But, it comes from Hyderabad," he said.
With major companies like Dr Reddy's Laboratories and Aurobindo Pharma also entering the area of vaccines, it is going to be a bigger game, he said.
He was speaking after receiving the Genome Valley Excellence Award for 2021.
The award given to him is not for him alone but goes to all entrepreneurs, Ella said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)